General Psychiatry

Questions discussed in this category

Do you avoid due to the increased risk of GI adverse events?

Do you taper memantine after completion of 24 weeks of therapy?

There does not appear to be any guidance from the most recent published protocols on this topic. For individuals with dementia, recommendations call f...

3 Answers available

What is the best way to manage severe claustrophobia and anxiety for Thermoplastic masks?

4 Answers available

Papers discussed in this category

Journal of psychiatric practice, 2018-11

Association Between Delusions of Infestation and Prescribed Narcotic and Stimulant Use.

Journal of the American Academy of Dermatology, 2019-05

Diagnosis and management of delusional parasitosis.

Med Hypotheses, 2006 Nov 28

Delusional parasitosis and the dopamine transporter. A new insight of etiology?

J Am Acad Dermatol, 2021 Apr 18

Stimulant use in patients presenting with psychocutaneous disorders.

Prog Neuropsychopharmacol Biol Psychiatry,

Effects of pimozide on the psychopathology of delusional disorder.

Antimicrob Agents Chemother, 2008 Nov 17

A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection.

Headache, 2010-06

The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.

Headache, 2012 Jan 30

Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.

Neurology, 2019 Dec 02

Triptan and ergotamine overdoses in the United States: Analysis of the National Poison Data System.

Headache, 2023 Jan 27

Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.

JAMA neurology, 2018-05-01

Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.

General Psychiatry

Questions discussed in this category

Papers discussed in this category

Related Topics